Exploration of biomarkers for cardiac sarcoidosis.

Exploration of biomarkers for cardiac sarcoidosis. - Exploration of biomarkers for cardiac sarcoidosis.

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000032905

Enrollment

Registered

2018-06-07

Start date

2017-06-06

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cardiac sarcoidosis

Interventions

Blood sampling (about 7 ml) is done one time from staffs of Tokyo Medical and Dental University. Separate serum after collection.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Staffs of Tokyo Medical and Dental University. We do not exclude by gender and age.

Exclusion criteria

Exclusion criteria: none.

Design outcomes

Primary

Measure	Time frame
We extract RNA and DNA from serum or circulating exosome, examine microRNA expression and mutation.	—

Secondary

Measure	Time frame
Measurement of exosome concentration in the circulating blood.	—

Countries

Japan

Contacts

Public ContactRyo Watanabe

Tokyo Medical and Dental University Department of Human Genetics and Disease Diversity

rwatcvm@tmd.ac.jp03-5803-4662

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026